Hopman Mark bought BBNX
February 27, 2026 · Form 4 insider transaction
Hopman Mark bought 109,105 shares of Beta Bionics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
109,105
Price
$0.00
Total value
N/A
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after140,320
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.